King Pharmaceuticals, Inc.

King Pharmaceuticals Reports Strong Third Quarter 2009 Financial Results [Press Release]
Business Wire | 15 days 17 hours 56 minutes ago
King Pharmaceuticals, Inc. (NYSE:KG) announced today that total revenues were $463 million during the third quarter ended September 30, 2009, compared to $388 million in the third quarter of 2008. The Company reported net income of $42 million and diluted earnings per share of $0.17 during the third quarter of 2009, compared to net income of $82 million and diluted earnings per share of $0.34 in the third quarter of the prior year. Excluding certain special items and recurring non-GAAP adjust...

King Pharmaceuticals to Present at Credit Suisse Healthcare Conference [Press Release]
Business Wire | 14 days 17 hours 56 minutes ago
King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to provide a live webcast of its presentation scheduled for Thursday, November 12, 2009, at 9:00 am Mountain Standard Time (11:00 am Eastern Standard Time), at the Credit Suisse 2009 Healthcare Conference at the Arizona Biltmore Hotel in Phoenix, Arizona. The presentation may include a discussion of the Company’s marketed products, pipeline, strategy for growth, financial results and expectations, and other matters relating to its bus...

King Pharmaceuticals Licenses Exclusive Rights to CYANOKIT in U.S. [Press Release]
Business Wire | 24 days 14 hours ago
King Pharmaceuticals, Inc. (NYSE:KG) announced today that it has licensed from Merck Santé S.A.S., an affiliate of Merck KGaA, Darmstadt, Germany, the exclusive rights to market and sell CYANOKIT® 5 g (hydroxocobalamin for injection) ANTIDOTE in the U.S. CYANOKIT® is indicated for the treatment of known or suspected cyanide poisoning, typically caused by smoke inhalation from fires.

King Pharmaceuticals Announces Date for Release of Third Quarter 2009 Earnings [Press Release]
Business Wire | 22 days 18 hours 56 minutes ago
King Pharmaceuticals, Inc. (NYSE:KG) announced today that the Company plans to report financial results for the third quarter ended September 30, 2009 prior to the market open on Thursday, November 5, 2009. The Company also plans to provide a live conference call which may include discussion of the Company’s marketed products, pipeline, financial results and expectations, and other matters relating to its business beginning at 11:00 a.m. ET that same day. This call will be open to all interes...

King Announces Commercial Availability of EMBEDA(TM) [Press Release]
PRNewswire | 60 days 18 hours 54 minutes ago
BRISTOL, Tenn., Sept. 21 /PRNewswire-FirstCall/ -- King Pharmaceuticals(R), Inc.

DURECT Signs Long Term Excipient Supply Agreement With King Pharmaceuticals for REMOXY(R) [Press Release]
PRNewswire | 85 days 17 hours 53 minutes ago
...Excipient Supply Agreement With King Pharmaceuticals for REMOXY(R) PRNewswire...respect to REMOXY(R) with King Pharmaceuticals, Inc. . This agreement stipulates...which DURECT will supply to King, based on DURECT's manufacturing...

With Economic Pain Contributing to Minor Strains and Sprains, King Pharmaceuticals(R), Inc. and RealAge.com Launch Effort to Educate Americans on Prevention and Treatment [Press Release]
PRNewswire | 60 days 17 hours 23 minutes ago
BRISTOL, Tenn., Sept. 21 /PRNewswire/ -- A new survey from the American Pain Foundation (APF) says economic pain from the recession is contributing to acute (short-term) physical pain for Americans.(1) In response to these findings, King Pharmaceuticals(R), Inc. has launched a consumer education initiative with RealAge.com to provide tips and information on preventing and treating strains and sprains of the back and other areas.

National Family Partnership Calls on Parents to 'Lock Your Meds' [Press Release]
PRNewswire | 24 days 12 hours 56 minutes ago
...stand against drug abuse. King Pharmaceuticals, Inc. is a proud partner of NFP...youth. NFP's sponsor, King Pharmaceuticals(R), Inc., headquartered in Bristol...branded pharmaceutical company. King, an S&P 500 Index company...

Critical Alerts for Hewlett-Packard, CME, Goldcorp, King Pharmaceuticals, and Manpower Released by Seven Summits Research [Press Release]
PRNewswire | 102 days 16 hours 23 minutes ago
... Today's PriceWatch Alerts cover the following stocks: Hewlett-Packard Company , CME Group Inc. , Goldcorp Inc. , King Pharmaceuticals Inc. , and Manpower Inc. . In today's unsure markets these brief PriceWatch Alerts contain concise...

Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain [Press Release]
PRNewswire | 99 days 9 hours 55 minutes ago
...PRNewswire-FirstCall/ -- King Pharmaceuticals((R)), Inc. today announced that...trademark of Alpharma Pharmaceuticals LLC, a wholly owned subsidiary of King Pharmaceuticals((R)), Inc. CONTACT: Investors...